Teva Pharmaceutical Industries Limited
TEVA
Rang in aandelen
#13238
Teva Pharmaceutical Industries Limited operates as a prominent global... Teva Pharmaceutical Industries Limited operates as a prominent global pharmaceutical firm, involved in the research, development, manufacturing, marketing, and distribution of generic, specialized, and biopharmaceutical products throughout North America, Europe, and other international regions. The company's diverse portfolio encompasses sterile preparations, hormonal therapies, high-potency drugs, and cytotoxic substances, supplied in a wide array of dosage forms such as tablets, capsules, injectable solutions, inhalants, oral liquids, transdermal patches, topical ointments, and creams. Furthermore, Teva develops, produces, and sells active pharmaceutical ingredients (APIs). A significant portion of its research and product development is concentrated on the central nervous system, pain management, respiratory illnesses, and oncology. Leading products for the central nervous system include Copaxone, utilized for relapsing multiple sclerosis; AJOVY, an option for migraine prevention; and AUSTEDO, prescribed for tardive dyskinesia and chorea linked to Huntington's disease. Within the respiratory domain, addressing asthma and chronic obstructive pulmonary disease, Teva offers products like ProAir, QVAR, various Digihaler and RespiClick formulations, along with BRALTUS and CINQAIR/CINQAERO. Their oncology division features treatments such as Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim. The company also collaborates with MedinCell on the creation and commercialization of multiple extended-release injectable products, including a risperidone suspension designed for individuals with schizophrenia. Teva Pharmaceutical Industries Limited was founded in 1901 and is headquartered in Tel Aviv-Yafo, Israel.
Aandeelprijs
$41.51
Laatst gesynchroniseerd: 2026-10-16
Marktkapitalisatie
$483.77M
Verandering (1 dag)
-0.85%
Verandering (1 jaar)
107.47%
Land
IL
Handel Teva Pharmaceutical Industries Limited (TEVA)
Categorie
Healthcare
Marktkapitalisatie van Teva Pharmaceutical Industries Limited(TEVA)
Marktkapitalisatie: $483.77M
Vanaf October 2026 heeft Teva Pharmaceutical Industries Limited een marktkapitalisatie van $483.77M. Dit maakt Teva Pharmaceutical Industries Limited volgens onze gegevens het 13238th meest waardevolle bedrijf ter wereld op basis van marktkapitalisatie. De marktkapitalisatie is de totale marktwaarde van alle uitstaande aandelen van een beursgenoteerd bedrijf en wordt vaak gebruikt om de waarde van een bedrijf te meten.
Marktkapitalisatiegeschiedenis van Teva Pharmaceutical Industries Limited van 2010 tot 2026
TEVA vergeleken met de top 5 populairste stocks
